Key Drivers
- Cash Generation
- Low Leverage
- Tight Margins
AIAI Summary
NHC should now be viewed less as a slow grower and more as a disciplined acquirer, with a strong balance sheet and rising dividend providing room to compound, but the investment case hinges on whether recently bought/owned assets can lift recurring margins and cash flow without leaning on acquisition gains or unrealized portfolio marks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Generation
- •Low Leverage
- •Tight Margins
NHC remains a high-quality, cash-generative healthcare operator with strong profitability and minimal debt, but its richer valuation and still-tight operating margins warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Strong rebound
- •Support holding
- •Resistance cap
NHC has stabilized after a sharp selloff, rebounding from $208.20 to $223.59 over the last month, but it remains capped below $228-$231 so the near-term trend is only neutral to slightly weak.
Sharp rebound from $208.20 to $223.59 signals aggressive buying after the selloff
Sentiment & News
Key News Insights:
- •Acquisition-led growth
- •Dividend maintained
- •Shareholder returns
NHC posted Q2 2026 revenue growth of 8.8% to $408.0 million, largely from a recent skilled nursing acquisition, while maintaining shareholder returns with a $0.67 quarterly dividend.
The results are modestly positive for NHC, signaling expansion through acquisition while reinforcing its income-oriented appeal to investors
Similar Companies in Healthcare
Other companies in the same sector with AI ratings